Mary Huber

822 total citations
28 papers, 568 citations indexed

About

Mary Huber is a scholar working on Molecular Biology, Immunology and Rheumatology. According to data from OpenAlex, Mary Huber has authored 28 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Rheumatology. Recurrent topics in Mary Huber's work include Urticaria and Related Conditions (5 papers), Mast cells and histamine (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Mary Huber is often cited by papers focused on Urticaria and Related Conditions (5 papers), Mast cells and histamine (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Mary Huber collaborates with scholars based in United States and Germany. Mary Huber's co-authors include Sandra F. Falkenhein, Charles W. Parker, Dean D. Metcalfe, Cem Akin, Knut Brockow, R.Nagaraja Rao, Jan R. Turner, Jonathan W. Paschal, Stuart Kuhstoss and Michael K. Hoffman and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Mary Huber

27 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Huber United States 11 245 157 149 145 139 28 568
Robert S. Byrum United States 9 146 0.6× 262 1.7× 138 0.9× 52 0.4× 47 0.3× 10 716
K. Ikai Japan 12 135 0.6× 115 0.7× 178 1.2× 55 0.4× 38 0.3× 33 677
J. Rivera United States 10 533 2.2× 190 1.2× 27 0.2× 99 0.7× 205 1.5× 11 910
Taketoshi Saijo Japan 10 100 0.4× 99 0.6× 197 1.3× 18 0.1× 52 0.4× 24 514
Ray Stepney United Kingdom 6 127 0.5× 140 0.9× 173 1.2× 20 0.1× 35 0.3× 8 490
Taisei Masuda Japan 6 117 0.5× 200 1.3× 97 0.7× 21 0.1× 57 0.4× 10 404
Björn Odlander Sweden 13 153 0.6× 173 1.1× 68 0.5× 12 0.1× 40 0.3× 18 482
Osamu Niide Japan 6 189 0.8× 100 0.6× 24 0.2× 25 0.2× 67 0.5× 7 398
Hiroshi Sumichika Japan 10 147 0.6× 57 0.4× 92 0.6× 90 0.6× 13 0.1× 19 435
Zachary R. Healy United States 9 91 0.4× 25 0.2× 61 0.4× 87 0.6× 57 0.4× 17 567

Countries citing papers authored by Mary Huber

Since Specialization
Citations

This map shows the geographic impact of Mary Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Huber more than expected).

Fields of papers citing papers by Mary Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Huber. The network helps show where Mary Huber may publish in the future.

Co-authorship network of co-authors of Mary Huber

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Huber. A scholar is included among the top collaborators of Mary Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Huber. Mary Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamazoe, Sayumi, Jason M. Hogan, Sean M. West, et al.. (2020). High-Throughput Platform to Identify Antibody Conjugation Sites from Antibody–Drug Conjugate Libraries. Bioconjugate Chemistry. 31(4). 1199–1208. 6 indexed citations
2.
3.
Russell, Anne F., et al.. (2012). Part 1. 3(4). 146–161. 2 indexed citations
4.
Passmore, David, Qian Zhang, Chin Pan, et al.. (2012). Abstract LB-252: Enzymology of the mechanism of action for MDX-1203 antibody drug conjugate. Cancer Research. 72(8_Supplement). LB–252. 2 indexed citations
5.
Rao, Chetana, Chin Pan, Mary Huber, et al.. (2010). Abstract 2452: Efficacy and toxicity of an anti-CD19 antibody drug conjugate. Cancer Research. 70(8_Supplement). 2452–2452. 2 indexed citations
6.
Pan, Chin, Jonathan Terrett, Chetana Rao, et al.. (2008). Human antibody conjugates of potential utility for prostate cancer therapy: A comparison of MGBA conjugates with antibodies targeting a cell surface target (prostate-specific membrane antigen) and an extracellular matrix target (Mindin/RG-1). Cancer Research. 68. 4062–4062. 1 indexed citations
7.
Brockow, Knut, Cem Akin, Mary Huber, & Dean D. Metcalfe. (2005). IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. Clinical Immunology. 115(2). 216–223. 70 indexed citations
8.
Brockow, Knut, Cem Akin, Mary Huber, & Dean D. Metcalfe. (2003). Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: Relationship to symptomatology, tryptase levels, and bone marrow pathology. Journal of the American Academy of Dermatology. 48(4). 508–516. 73 indexed citations
9.
Brockow, Knut, Linda M. Scott, Alexandra S. Worobec, et al.. (2002). Regression of Urticaria Pigmentosa in Adult Patients With Systemic Mastocytosis. Archives of Dermatology. 138(6). 785–90. 22 indexed citations
10.
Brockow, Knut, Cem Akin, Mary Huber, et al.. (2002). Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: Correlation with dermal mast-cell numbers and mast-cell tryptase. Journal of Allergy and Clinical Immunology. 109(1). 82–88. 47 indexed citations
11.
Brockow, Knut, Cem Akin, Mary Huber, & Dean D. Metcalfe. (2002). Plasma IL-6 correlates with disease category and with hematological parameters in patients with mastocytosis. Journal of Allergy and Clinical Immunology. 109(1). S158–S158. 2 indexed citations
12.
Huber, Mary, et al.. (2000). Immunostimulatory activity of the bacterial extract OM-8.. PubMed. 5(3). 101–9. 6 indexed citations
13.
Kuhstoss, Stuart, Mary Huber, Jan R. Turner, Jonathan W. Paschal, & R.Nagaraja Rao. (1996). Production of a novel polyketide through the construction of a hybrid polyketide synthase. Gene. 183(1-2). 231–236. 93 indexed citations
14.
Huber, Mary, et al.. (1985). HEREDITARY ANGIOEDEMA. AJN American Journal of Nursing. 85(10). 1090–1090. 1 indexed citations
15.
Parker, Charles W., et al.. (1983). Induction of Ige Receptors on Human Lymphocytes. Immunological Communications. 12(1). 1–10. 8 indexed citations
16.
Parker, Charles W., Mary Huber, & Sandra F. Falkenhein. (1982). [76] Pharmacologic characterization of slow-reacting substances. Methods in enzymology on CD-ROM/Methods in enzymology. 86. 655–667. 1 indexed citations
17.
Parker, Charles W., Sandra F. Falkenhein, & Mary Huber. (1982). [54] Production and purification of slow-reacting substance (SRS) from RBL-1 cells. Methods in enzymology on CD-ROM/Methods in enzymology. 86. 416–426. 3 indexed citations
18.
19.
Parker, Charles W., et al.. (1980). Incorporation of radiolabel from [1-14C]5-hydroperoxy-eicosatetraenoic acid into slow reacting substance. Biochemical and Biophysical Research Communications. 94(4). 1037–1043. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert S. Byrum Breakdown of academic impact, for papers by K. Ikai Breakdown of academic impact, for papers by J. Rivera Breakdown of academic impact, for papers by Taketoshi Saijo Breakdown of academic impact, for papers by Ray Stepney Breakdown of academic impact, for papers by Taisei Masuda Breakdown of academic impact, for papers by Björn Odlander Breakdown of academic impact, for papers by Osamu Niide Breakdown of academic impact, for papers by Hiroshi Sumichika Breakdown of academic impact, for papers by Zachary R. Healy
Rankless by CCL
2026